We are live on ! Find out more
TMCI icon

Treace Medical Concepts
TMCI

138 hedge funds and large institutions have $315M invested in Treace Medical Concepts in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 46 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,452% more call options, than puts

Call options by funds: $388K | Put options by funds: $25K

16% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 25

14% more capital invested

Capital invested by funds: $278M → $315M (+$37.5M)

2% more funds holding

Funds holding: 135 → 138 (+3)

0.7% more ownership

Funds ownership: 59.88% → 60.58% (+0.7%)

11% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 46

Holders
138
Holders Change
+3
Holders Change %
+2.22%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
29
Increased
41
Reduced
46
Closed
25
Calls
$388K
Puts
$25K
Net Calls
+$363K
Net Calls Change
-$704K

Top Buyers

Rank Fund Capital Flow
1
PHP
Parkman Healthcare Partners
Connecticut
+$6.41M
2
First Eagle Investment Management
First Eagle Investment Management
New York
+$4.48M
3
DCM
Driehaus Capital Management
Illinois
+$4.21M
4
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$3.64M
5
SSA
Schonfeld Strategic Advisors
New York
+$3.47M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.48M
2
UBS Group
UBS Group
Switzerland
-$5.46M
3
N
Nuveen
North Carolina
-$1.98M
4
Goldman Sachs
Goldman Sachs
New York
-$1.84M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$2.18M -$1.84M -205,227 -44%
N
27
Nuveen
North Carolina
$2.12M -$1.98M -220,140 -47%
LCG
28
Lisanti Capital Growth
New York
$2.12M +$2.27M +252,215 New
Wealth Enhancement Advisory Services
29
Wealth Enhancement Advisory Services
Minnesota
$2.05M +$23.8K +2,645 +1%
AWMNY
30
Arcadia Wealth Management (New York)
New York
$1.76M +$1.89M +209,972 New
Stifel Financial
31
Stifel Financial
Missouri
$1.58M -$8.9K -990 -0.5%
BC
32
Birchview Capital
Vermont
$1.38M +$32.3K +3,597 +2%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$1.3M +$681K +75,726 +95%
UOC
34
UBS O'Connor
Illinois
$1.24M -$1.14M -126,505 -46%
SFI
35
Susquehanna Fundamental Investments
Pennsylvania
$1.14M -$12K -1,337 -1%
Renaissance Technologies
36
Renaissance Technologies
New York
$1.06M +$133K +14,800 +13%
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$1.06M +$455K +50,669 +67%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.03M -$32.6K -3,628 -3%
AI
39
Accredited Investors
Minnesota
$839K – – –
GF
40
Gabelli Funds
New York
$776K – – –
Los Angeles Capital Management
41
Los Angeles Capital Management
California
$717K +$768K +85,465 New
PP
42
PDT Partners
New York
$709K +$497K +55,336 +190%
Fuller & Thaler Asset Management
43
Fuller & Thaler Asset Management
California
$707K +$9.12K +1,015 +1%
Connor, Clark & Lunn Investment Management (CC&L)
44
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$692K +$329K +36,566 +80%
Two Sigma Investments
45
Two Sigma Investments
New York
$682K -$652K -72,521 -47%
Raymond James Financial
46
Raymond James Financial
Florida
$628K +$199K +22,133 +42%
Dimensional Fund Advisors
47
Dimensional Fund Advisors
Texas
$601K – – –
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$587K +$34.5K +3,843 +6%
Fidelity Investments
49
Fidelity Investments
Massachusetts
$573K -$26.1K -2,900 -4%
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$560K +$495K +55,025 +469%
1
2
3 4 5

TMCI Hedge Fund Activity: Q1 2025 in Review

138 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2025, worth a combined $315M — up 14% from $278M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TMCI positions and 25 closed out — a net gain of 4 holders — while 41 added to existing stakes and 46 trimmed.

The largest buyer was Parkman Healthcare Partners, opening a new position worth an estimated $6.41M. The largest seller was Morgan Stanley, cutting an estimated $5.48M.

  • 138 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2025, up from 135 in Q4 2024.
  • Funds reported $315M of Treace Medical Concepts stock for Q1 2025, up 14% quarter-over-quarter.
  • 29 funds opened new Treace Medical Concepts positions in Q1 2025 and 25 closed out, a net change of +4 holders.
  • The largest Treace Medical Concepts buyer in Q1 2025 was Parkman Healthcare Partners, an estimated $6.41M added.
  • The largest Treace Medical Concepts seller in Q1 2025 was Morgan Stanley, an estimated $5.48M sold.

Based on aggregated 13F filings for Q1 2025.